Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

NKTR Stock Forecast, Price Targets, Chart, Dividends & Analysis

Nektar Therapeutics logo

Nektar Therapeutics

Sector: Healthcare   

Industry: Biotechnology

1.40
 
USD
  
0.03
  
(2.19%)
Previous close: 1.37  Open: 1.38  Bid: 1.3  Ask: 1.4
52 week range    
0.41   
   1.93
Mkt Cap: 258 M  Avg Vol (90 Days): 1,198,874
Peers   
PFE / 
MRK / 
AMGN / 
ENZN / 
BAX / 
JNJ / 
AZN / 
RELL / 
NVS / 
Last updated: Monday 11th November 2024

Stock Rankings

56
MarketXLS Rank
60
Value
69
Technical
39
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

AFFY

AMGN

0.0277172 B40.27325.28

AZN

BAX

0.033518 B7.3834.64

ENZN

JNJ

0.0319381 B25.95155.47

MRK

0.0299258 B18.8102.92

NVS

PFE

0.0629159 B7226.72

RELL

0.01640 B14.65
Financials

NKTR Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Amortization of intangibles77 M
Basic EPS from continuing operations-2.52-2.49-2.86-1.97-1.45
Basic EPS total-0.35-0.4-0.28-0.624.02-2.52-2.49-2.86-1.97-1.45
Basic weighted shares outstanding127 M132 M140 M156 M170 M175 M179 M183 M187 M190 M
Cost of sales-29 M-34 M-30 M-31 M-24 M21 M19 M25 M22 M34 M
Depreciation-12 M-11 M-13 M-13 M-9 M11 M13 M13 M12 M7 M
DepreciationAndAmortization-12 M-11 M-13 M-13 M-9 M11 M13 M13 M12 M7 M
Diluted EPS total-0.42-0.61-1.1-0.623.78-2.52-2.49-2.86-1.97-1.45
Diluted normalized net income/share-2.52-2.49-2.86-1.97-1.45
Diluted weighted shares outstanding128 M133 M140 M156 M180 M175 M179 M183 M187 M190 M
GainOnSaleOfPPE-8 M3 M-1 M
GainOnSaleOfSecurity22 M43 M79000.0-533000.0
GeneralAndAdministrativeExpense41 M43 M44 M52 M81 M99 M105 M123 M92 M77 M
Gross operating profit172 M197 M135 M261 M1,169 M93 M133 M77 M70 M56 M
ImpairmentOfCapitalAssets66 M77 M
Income before tax-54 M-81 M-153 M-96 M683 M-440 M-444 M-523 M-365 M-276 M
Income restructuring and M&A136 M52 M
Income taxes-512000.0506000.0876000.0616000.01 M613000.0493000.0557000.03 M-200000.0
Interest income-21 M-21 M-20 M-19 M-21 M7 M19 M
InterestExpenseNonOperating18 M18 M22 M22 M22 M21 M37 M47 M29 M25 M
InterestExpenseOperating-17 M-20 M-21 M-20 M
MiscOtherSpecialCharges814000.0-12 M2 M5 M38 M21 M-12 M-69 M4 M-32 M
Net income from total operations-54 M-81 M-154 M-97 M681 M-441 M-444 M-524 M-368 M-276 M
NetIncomeCommonStockholders-54 M-81 M-154 M-97 M681 M-441 M-444 M-524 M-368 M-276 M
NetIncomeContinuousOperations-54 M-81 M-154 M-97 M681 M-441 M-444 M-524 M-368 M-276 M
NetNonOperatingInterestIncomeExpense-39 M-39 M-42 M-41 M-43 M-21 M-7 M7 M6 M
Normalized income-110 M
Operating income-16 M-29 M-113 M-60 M688 M-440 M-425 M-446 M-376 M-264 M
Operating income before depreciation (EBITDA)-41 M-70 M-135 M-79 M715 M-406 M-393 M-462 M-323 M-243 M
OperatingExpense189 M226 M248 M321 M481 M533 M513 M523 M311 M192 M
Other income net-814000.012 M-2 M-5 M-38 M-21 M12 M69 M-4 M-135 M
OtherGandA41 M43 M44 M52 M81 M99 M105 M123 M92 M77 M
OtherImpairmentOfCapitalAssets68 M37 M
OtherOperatingExpenses-8 M-50 M-3 M-2 M-378000.0-848000.0
OtherWriteDown-2 M
RentAndLandingFees41 M43 M44 M52 M81 M
Research & development expense148 M183 M204 M268 M400 M435 M409 M400 M218 M114 M
ResearchExpense148 M183 M204 M268 M400 M435 M409 M400 M218 M114 M
RestructringAndMnAIncome136 M52 M
Revenue per share79 M2 M
SalariesAndWages-17 M-20 M-26 M-37 M-88 M
Selling Gen & administrative expense41 M43 M44 M52 M81 M99 M105 M123 M92 M77 M
Special income/charges-136 M-128 M
Total Income available for interest expense (EBIT)-54 M-83 M-151 M-94 M704 M-419 M-407 M-476 M-336 M-251 M
Total common shares outstanding131 M136 M154 M161 M174 M178 M182 M186 M189 M
Total net income-54 M-81 M-154 M-97 M681 M-441 M-444 M-524 M-368 M-276 M
Total ordinary shares184 M184 M184 M184 M184 M184 M184 M184 M184 M184 M
Total revenues201 M231 M165 M308 M1,193 M115 M153 M94 M92 M90 M
TotalExpenses160 M192 M218 M290 M457 M555 M533 M548 M332 M225 M
TotalRevenue25 M40 M55 M308 M1,193 M115 M153 M102 M92 M90 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University